Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 348 shares of common stock on March 27, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On March 27, 2024, Brian Adams, the Chief Legal Officer of Relay Therapeutics, sold 348 shares of the company's common stock.
- The sale was executed at a price of $7.7 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 992 restricted stock units (RSUs) on March 26, 2024.
- Following the transaction, Adams beneficially owns 327,390 shares of Relay Therapeutics, which includes 296,825 shares underlying RSUs.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no indication of positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock. This filing indicates a routine transaction to cover tax obligations related to vested equity.
Key Dates
| Date | Description |
|---|---|
| 03/26/2024 | Vesting of 992 restricted stock units (RSUs) |
| 03/27/2024 | Sale of 348 shares of common stock by Brian Adams |
| 03/29/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.